Literature DB >> 30366560

Prion Diseases.

Boon Lead Tee1, Erika Mariana Longoria Ibarrola2, Michael D Geschwind3.   

Abstract

Prions diseases are uniformly fatal neurodegenerative diseases that occur in sporadic, genetic, and acquired forms. Acquired prion diseases, caused by infectious transmission, are least common. Most prion diseases are not infectious, but occur spontaneously through misfolding of normal prion proteins or genetic mutations in the prion protein gene. Although most prion diseases are not caused by infection, they can be transmitted accidentally. Certain infection control protocols should be applied when handling central nervous system and other high-risk tissues. New diagnostic methods are improving premortem and earlier diagnosis. Treatment trials have not shown improved survival, but therapies may be available soon.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CJD; Creutzfeldt-Jakob disease; Jakob-Creutzfeldt disease; Protein misfolding disorders; Rapidly progressive dementia; Transmissible spongiform encephalopathies

Mesh:

Year:  2018        PMID: 30366560     DOI: 10.1016/j.ncl.2018.07.005

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  14 in total

Review 1.  Ataxia.

Authors:  Sheng-Han Kuo
Journal:  Continuum (Minneap Minn)       Date:  2019-08

Review 2.  The importance of ongoing international surveillance for Creutzfeldt-Jakob disease.

Authors:  Neil Watson; Jean-Philippe Brandel; Alison Green; Peter Hermann; Anna Ladogana; Terri Lindsay; Janet Mackenzie; Maurizio Pocchiari; Colin Smith; Inga Zerr; Suvankar Pal
Journal:  Nat Rev Neurol       Date:  2021-05-10       Impact factor: 42.937

3.  Serpin Signatures in Prion and Alzheimer's Diseases.

Authors:  Marco Zattoni; Marika Mearelli; Silvia Vanni; Arianna Colini Baldeschi; Thanh Hoa Tran; Chiara Ferracin; Marcella Catania; Fabio Moda; Giuseppe Di Fede; Giorgio Giaccone; Fabrizio Tagliavini; Gianluigi Zanusso; James W Ironside; Isidre Ferrer; Giuseppe Legname
Journal:  Mol Neurobiol       Date:  2022-04-13       Impact factor: 5.682

4.  Melatonin regulates mitochondrial dynamics and alleviates neuron damage in prion diseases.

Authors:  Xixi Zhang; Deming Zhao; Wei Wu; Syed Zahid Ali Shah; Mengyu Lai; Dongming Yang; Jie Li; Zhiling Guan; Wen Li; Hongli Gao; Huafen Zhao; Xiangmei Zhou; Lifeng Yang
Journal:  Aging (Albany NY)       Date:  2020-06-10       Impact factor: 5.682

5.  Movement Disorders in Prionopathies: A Systematic Review.

Authors:  Federico Rodriguez-Porcel; Vinícius Boaratti Ciarlariello; Alok K Dwivedi; Lilia Lovera; Gustavo Da Prat; Ricardo Lopez-Castellanos; Ritika Suri; Holly Laub; Ruth H Walker; Orlando Barsottini; José Luiz Pedroso; Alberto J Espay
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2019-12-12

6.  Corticobasal manifestations of Creutzfeldt-Jakob disease with D178N-homozygous 129M genotype.

Authors:  Yumeng Huang; Ma Jianfang; Rodrigo Morales; Huidong Tang
Journal:  Prion       Date:  2020-12       Impact factor: 3.931

7.  Spin Label Scanning Reveals Likely Locations of β-Strands in the Amyloid Fibrils of the Ure2 Prion Domain.

Authors:  Jingzhou Wang; Giovanna Park; Yoon Kyung Lee; Matthew Nguyen; Tiffany San Fung; Tiffany Yuwen Lin; Frederick Hsu; Zhefeng Guo
Journal:  ACS Omega       Date:  2020-03-11

Review 8.  Multifunctional Polymeric Nanoplatforms for Brain Diseases Diagnosis, Therapy and Theranostics.

Authors:  Shahryar Shakeri; Milad Ashrafizadeh; Ali Zarrabi; Rasoul Roghanian; Elham Ghasemipour Afshar; Abbas Pardakhty; Reza Mohammadinejad; Anuj Kumar; Vijay Kumar Thakur
Journal:  Biomedicines       Date:  2020-01-13

Review 9.  Challenges and Advances in Antemortem Diagnosis of Human Transmissible Spongiform Encephalopathies.

Authors:  Lucas M Ascari; Stephanie C Rocha; Priscila B Gonçalves; Tuane C R G Vieira; Yraima Cordeiro
Journal:  Front Bioeng Biotechnol       Date:  2020-10-20

10.  Altered cellular localisation and expression, together with unconventional protein trafficking, of prion protein, PrPC, in type 1 diabetes.

Authors:  Helmut Hiller; Changjun Yang; Dawn E Beachy; Irina Kusmartseva; Eduardo Candelario-Jalil; Amanda L Posgai; Harry S Nick; Desmond Schatz; Mark A Atkinson; Clive H Wasserfall
Journal:  Diabetologia       Date:  2021-07-17       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.